TITLE:
A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment

CONDITION:
HIV Infections

INTERVENTION:
Lamivudine/Zidovudine

SUMMARY:

      The purpose of this study is to compare 2 combination drug therapies in HIV-infected
      patients who have never received anti-HIV treatment.
    

DETAILED DESCRIPTION:

      In this open-label study antiretroviral-naive patients are randomized to one of two drug
      regimens:

      Arm I: 141W94 (amprenavir), 1592U89 (abacavir), and Combivir (3TC/AZT tablet). Arm II:
      Nelfinavir and Combivir.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria

        Patients must have:

          -  CD4 count > 50.

          -  HIV RNA > 5,000.

          -  No active AIDS (excluding CD4 count < 200).

          -  Ability to comply with dosing schedule and protocol evaluations.

        Prior Medication:

        Allowed:

          -  3TC or any protease inhibitor, if < 1 week of therapy.

          -  Other nucleoside analogs, if < 4 weeks of therapy.

        Exclusion Criteria

        Co-existing Condition:

        Patients with any of the following symptoms or conditions are excluded:

          -  Active AIDS (not including CD4 count < 200).

          -  Malabsorption syndrome affecting drug absorption.

        Concurrent Medication:

        Excluded:

        Enrollment in any other investigational drug protocol.

        Prior Medication:

        Excluded:

        Non-nucleoside reverse transcriptase inhibitors.
      
